Anders Wimo

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. doi The worldwide economic impact of dementia 2010
    Anders Wimo
    KI Alzheimer Disease Research Centre, Karolinska Institutet, Stockholm, Sweden
    Alzheimers Dement 9:1-11.e3. 2013
  2. ncbi Time use and costs of institutionalised elderly persons with or without dementia: results from the Nordanstig cohort in the Kungsholmen Project--a population based study in Sweden
    Gunilla Nordberg
    Aging Research Center ARC, Karolinska Institutet, Stockholm, Sweden
    Int J Geriatr Psychiatry 22:639-48. 2007
  3. ncbi Determinants of costs of care for patients with Alzheimer's disease
    Linus Jönsson
    Division of Geriatric Epidemiology, The Neurotec Department, Karolinska Institutet, Stockholm, Sweden
    Int J Geriatr Psychiatry 21:449-59. 2006
  4. doi Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry
    Anders Wimo
    KI Alzheimer Disease Research Center KI ADRC, Department of Neurobiology, Caring Sciences and Society, Karolinska Institute Stockholm, Stockholm, Sweden The Primary Health Care of Hudiksvall Nordanstig, Bergsjö, Sweden
    Int J Geriatr Psychiatry 28:1039-44. 2013
  5. ncbi Clinical and economic outcomes--friend or foe?
    Anders Wimo
    Department of Neurobiology, Care and Society, Karolinska University Hospital, Stockholm, Sweden
    Int Psychogeriatr 19:497-507. 2007
  6. doi Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease
    Niklas Bergvall
    i3 Innovus, Stockholm, Sweden
    Int Psychogeriatr 23:73-85. 2011
  7. ncbi Health utilities in mild cognitive impairment and dementia: a population study in Sweden
    Mattias Ekman
    Stockholm Health Economics, Stockholm, Sweden
    Int J Geriatr Psychiatry 22:649-55. 2007
  8. ncbi The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings
    Anders Wimo
    KI Alzheimer s Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden
    J Alzheimers Dis 36:385-99. 2013
  9. doi Morbidity and physical functioning in old age: differences according to living area
    Britt Marie Sjölund
    Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden
    J Am Geriatr Soc 58:1855-62. 2010
  10. doi Predictors of costs of care in Alzheimer's disease: a multinational sample of 1222 patients
    Anders Gustavsson
    Alzheimer s Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden
    Alzheimers Dement 7:318-27. 2011

Detail Information

Publications34

  1. doi The worldwide economic impact of dementia 2010
    Anders Wimo
    KI Alzheimer Disease Research Centre, Karolinska Institutet, Stockholm, Sweden
    Alzheimers Dement 9:1-11.e3. 2013
    ..To acquire an understanding of the societal costs of dementia and how they affect families, health and social care services, and governments to improve the lives of people with dementia and their caregivers...
  2. ncbi Time use and costs of institutionalised elderly persons with or without dementia: results from the Nordanstig cohort in the Kungsholmen Project--a population based study in Sweden
    Gunilla Nordberg
    Aging Research Center ARC, Karolinska Institutet, Stockholm, Sweden
    Int J Geriatr Psychiatry 22:639-48. 2007
    ..The aging of the population has become a worldwide phenomenon. This leads to increased demand for services and with limited resources it is important to find a way to estimate how resources can be match to those with greatest need...
  3. ncbi Determinants of costs of care for patients with Alzheimer's disease
    Linus Jönsson
    Division of Geriatric Epidemiology, The Neurotec Department, Karolinska Institutet, Stockholm, Sweden
    Int J Geriatr Psychiatry 21:449-59. 2006
    ..Alzheimer's disease (AD), the most common cause of dementia, is a major cause of disability and care burden in the elderly. This study aims to estimate the costs of formal and informal care and identity determinants of care costs...
  4. doi Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry
    Anders Wimo
    KI Alzheimer Disease Research Center KI ADRC, Department of Neurobiology, Caring Sciences and Society, Karolinska Institute Stockholm, Stockholm, Sweden The Primary Health Care of Hudiksvall Nordanstig, Bergsjö, Sweden
    Int J Geriatr Psychiatry 28:1039-44. 2013
    ..Here, we examine the costs of diagnostic dementia work-up in Sweden...
  5. ncbi Clinical and economic outcomes--friend or foe?
    Anders Wimo
    Department of Neurobiology, Care and Society, Karolinska University Hospital, Stockholm, Sweden
    Int Psychogeriatr 19:497-507. 2007
    ..Both dementia-specific and generic quality of life instruments are required. Models are necessary but must be transparent so that the assumptions on which the models are built can be critically analyzed...
  6. doi Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease
    Niklas Bergvall
    i3 Innovus, Stockholm, Sweden
    Int Psychogeriatr 23:73-85. 2011
    ..However, the direct effect and relative importance of each disease severity measure remains unclear...
  7. ncbi Health utilities in mild cognitive impairment and dementia: a population study in Sweden
    Mattias Ekman
    Stockholm Health Economics, Stockholm, Sweden
    Int J Geriatr Psychiatry 22:649-55. 2007
    ..To collect new primary data on community-based health utilities (time trade-off values) in different stages of mild cognitive impairment and dementia from a general population sample...
  8. ncbi The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings
    Anders Wimo
    KI Alzheimer s Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden
    J Alzheimers Dis 36:385-99. 2013
    ..Informal care costs formed the greatest proportion of total societal costs, increasing with AD severity independent of costing method. Longitudinal data will provide information on cost trends with disease progression...
  9. doi Morbidity and physical functioning in old age: differences according to living area
    Britt Marie Sjölund
    Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden
    J Am Geriatr Soc 58:1855-62. 2010
    ..To describe differences in morbidity and functional status according to living area...
  10. doi Predictors of costs of care in Alzheimer's disease: a multinational sample of 1222 patients
    Anders Gustavsson
    Alzheimer s Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden
    Alzheimers Dement 7:318-27. 2011
    ..We aimed to identify what measures of disease severity are the most important predictors of societal costs of care and whether their relationship differs across countries...
  11. doi Application of Resource Utilization in Dementia (RUD) instrument in a global setting
    Anders Wimo
    KI Alzheimer Disease Research Centre, Karolinska Institutet, Sweden
    Alzheimers Dement 9:429-435.e17. 2013
    ..The aim of this study was to update the RUD to improve its face validity in Alzheimer's disease (AD) clinical research and its utility for health care resource allocation...
  12. doi The cost of dementia in Europe: a review of the evidence, and methodological considerations
    Linus Jönsson
    i3 Innovus, Stockholm, Sweden
    Pharmacoeconomics 27:391-403. 2009
    ..Patient-level information on resource use is required to analyse determinants of care costs and predict the impact of therapeutic interventions. More data are needed to support future economic evaluations of therapies for AD...
  13. doi The worldwide societal costs of dementia: Estimates for 2009
    Anders Wimo
    KI Alzheimer s Disease Research Center, Department of Neurobiology, Karolinska Institutet, Stockholm, Sweden
    Alzheimers Dement 6:98-103. 2010
    ..The purpose of this study was to update the previous estimate of the worldwide cost of dementia in 2005 to 2009...
  14. ncbi Mortality and treatment costs have a great impact on the cost-effectiveness of disease modifying treatment in Alzheimer's disease--a simulation study
    Anders Sköldunger
    Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden
    Curr Alzheimer Res 10:207-16. 2013
    ..It is of vital importance to develop and identify cost effective treatment. The aim of the study was to present a hypothetical economic model of Disease Modifying Treatment (DMT) in AD...
  15. ncbi Practical lessons from amyloid immunotherapy trials in Alzheimer disease
    Alina Solomon
    Aging Research Center ARC, Department of Neurobiology, Care Sciences and Society Karolinska Institutet, Stockholm, Sweden
    Curr Alzheimer Res 9:1126-34. 2012
    ..This study investigates practical experiences of staff and participants in immunotherapy RCTs...
  16. doi Dementia diagnosis differs in men and women and depends on age and dementia severity: data from SveDem, the Swedish Dementia Quality Registry
    Dorota Religa
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
    Dement Geriatr Cogn Disord 33:90-5. 2012
    ..We examine the dementia assessment with focus on age and gender differences...
  17. ncbi Societal burden and economics of vascular dementia: preliminary results from a Swedish-population-based study
    Anders Wimo
    Neurotec, Division of Geriatric Epidemiology, Karolinska Institutet, Stockholm, Sweden
    Int Psychogeriatr 15:251-6. 2003
    ..The cost from a societal perspective was 23% higher for patients with VaD compared with patients with Alzheimer's disease ( p = .02)...
  18. ncbi Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL
    Linus Jönsson
    Neurotec, Section for Geriatric Epidemiology, Karolinska Institutet, Stockholm, Sweden
    Alzheimer Dis Assoc Disord 20:49-55. 2006
    ..The study shows that the EuroQoL can be used to rate utilities in Alzheimer disease, but there are important differences between patient- and proxy-ratings...
  19. doi Net costs of dementia in Sweden - an incidence based 10 year simulation study
    Anders Sköldunger
    NVS, Aging Research Center, Karolinska Institutet, Stockholm, Sweden
    Int J Geriatr Psychiatry 27:1112-7. 2012
    ..Therefore, modeling approaches are frequently used. The purpose of this study was to describe the costs of an incident dementia cohort with progression modeling...
  20. doi The economic impact of galantamine vs placebo: an analysis based on functional capacity in a Swedish cohort study
    Anders Wimo
    Aging Research Center, Dept NVS, Karolinska Institutet, Stockholm, Sweden
    J Med Econ 15:1019-24. 2012
    ..To analyse the economic impact of galantamine, based on basic activities of daily living (ADL)...
  21. doi Willingness-to-pay for reductions in care need: estimating the value of informal care in Alzheimer's disease
    Anders Gustavsson
    Department of Neurobiology, Care Sciences and Society, Alzheimeŕs Disease Research Center, Karolinska Institutet, Novum Plan 5, Stockholm, Sweden
    Int J Geriatr Psychiatry 25:622-32. 2010
    ..To estimate the value of informal care in Alzheimer's disease using contingent valuation...
  22. doi The cost of diagnosing dementia in a community setting
    Erik Jedenius
    Alzheimer s Disease Research Centre, Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Stockholm, Sweden
    Int J Geriatr Psychiatry 25:476-82. 2010
    ..Further, in order to establish prerequisites for care and planning it is important to identify the cost of dementia diagnosis. This study aims to evaluate the cost of establishing a dementia diagnosis...
  23. pmc A Swedish programme for dementia diagnostics in primary healthcare
    Erik Jedenius
    Alzheimer s Disease Research Centre, Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Stockholm, Sweden
    Scand J Prim Health Care 26:235-40. 2008
    ..To meet diagnostic needs of dementia, a new care programme was implemented in the county of Kalmar, Sweden. The objective of the study was to analyse whether the programme could identify and diagnose the estimated number of new cases...
  24. ncbi The use of angiotensin-converting enzyme inhibitors and other drugs with cardiovascular effects by non-demented and demented elderly with a clinical diagnosis of heart failure. A population-based study of the very old
    Inga Klarin
    Aging Research Center, Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Gavlegatan 16, 113 30, Stockholm, Sweden
    Eur J Clin Pharmacol 62:555-62. 2006
    ..The aim of this study was to investigate drug treatment patterns for heart failure (HF) in the very elderly and, in particular, to determine if angiotensin-converting enzyme inhibitors (ACEIs) were under-used by demented persons...
  25. ncbi The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old
    Inga Klarin
    Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
    Drugs Aging 22:69-82. 2005
    ..The aim of this study was to explore possible associations of IDU with acute hospitalisation and mortality in an elderly population during 3 years of follow-up...
  26. ncbi Validity and reliability of assessments of time. Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument
    Anders Wimo
    Aging Research Center ARC, Division of Geriatric Epidemiology and Medicine, Neurotec, Karolinska Institutet, Huddinge Hospital, B84, S 141 86 Stockholm, Sweden
    Arch Gerontol Geriatr 44:71-81. 2007
    ..9). There was a high correlation between interview-based data and register data regarding hospital care, family physician, and district nurse visits. In conclusion, interviews may serve as a valid and reliable substitute for observations...
  27. ncbi Impact of donepezil treatment for Alzheimer's disease on caregiver time
    Anders Wimo
    Karolinska Institutet, Huddinge, Sweden
    Curr Med Res Opin 20:1221-5. 2004
    ..To assess the impact of donepezil treatment compared with placebo on caregiver time spent assisting patients with Alzheimer's disease (AD)...
  28. doi Cost-effectiveness of a health intervention program with risk reductions for getting demented: results of a Markov model in a Swedish/Finnish setting
    Yanlei Zhang
    Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
    J Alzheimers Dis 26:735-44. 2011
    ..This is a promising outlook for future research on preventive interventions in dementia, emphasizing the need of conducting multi-domain randomized trials...
  29. ncbi Pharmacoeconomics of mild cognitive impairment
    Anders Wimo
    Division of Geriatric Medicine, Neurotec, Karolinska Institutet, Stockholm, Sweden
    Acta Neurol Scand Suppl 179:94-9. 2003
    ..From the Kungsholmen project in Sweden, there are indications that the postponement between MCI and manifest dementia may result in short-term benefits (a few years) of about SEK50,000 (5300 US dollars)...
  30. ncbi The magnitude of dementia occurrence in the world
    Anders Wimo
    Aging Research Center, Karolinska Institutet, Stockholm, Sweden
    Alzheimer Dis Assoc Disord 17:63-7. 2003
    ..In conclusion, the majority of demented elders live in less developed regions, and this proportion will increase considerably in the future...
  31. ncbi A longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC)
    Marten Lagergren
    Stockholm Gerontology Research Center, Stockholm, Sweden
    Aging Clin Exp Res 16:158-68. 2004
    ..A large, national, long-term, longitudinal, multi-purpose study has been launched in Sweden--the Swedish National study on Aging and Care (SNAC). The study involves four research centers collecting data in four different areas of Sweden...
  32. ncbi Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease: a review with methodological considerations
    Anders Wimo
    Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
    Drugs Aging 21:279-95. 2004
    ....
  33. ncbi A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort
    Inga Klarin
    Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Sweden
    Pharmacoepidemiol Drug Saf 12:669-78. 2003
    ..To describe drug use among the elderly, with focus on cardiovascular drugs and regional differences...
  34. ncbi An estimate of the total worldwide societal costs of dementia in 2005
    Anders Wimo
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
    Alzheimers Dement 3:81-91. 2007
    ..CONCLUSIONS: Worldwide costs for dementia are enormous, and informal care constitutes a major cost component, in particular in less developed regions. The health economics of dementia is a highly relevant area for further research...